What to Expect

Thank you for your interest in Gliogene. If you and a blood-relative have both been diagnosed with glioma, you may be eligible to participate in this study. Treating and recovering from a brain tumor is a difficult experience, but we've designed the procedure so that participating in Gliogene will not contribute to that burden.

  • First, contact us using the information below to answer several questions about your family history of cancer.
  • Next, you'll be contacted by one of our research coordinators for a 45-minute interview. We'll ask you questions about your health, demographics, lifestyle, and experiences. We'll also contact your relative with glioma and ask the same questions.
  • You and your relative, if possible, will provide a saliva sample and a blood sample. For your convenience, the blood sample can be coordinated with your next doctor's appointment.

Contact Us to Participate

Frequently Asked Questions

Am I eligible?

You may be eligible if you and a biologically related family member have both been diagnosed with glioma. You may still participate even if your relative with glioma is deceased. Examples of glioma include astrocytoma, oligodendroglioma, and glioblastoma multiforme. The only way to know for certain whether or not you're eligible is to fill out the participation form.

Do I need to live nearby?

No, you do not need to live near Stanford.  The study can be completed entirely by phone and mail.  We can only include United States residents since it is hard to mail samples Internationally.

Is it confidential?

Yes, all information that you provide, as well as your sample results, are kept entirely confidential and private. No one outside this study may access your information without your permission.

What does it cost?

There's no cost to participate in this study. We'll provide pre-addressed mailings for you to mail your sample to us.

What if I have other questions?

We'll be glad to answer any questions you may have about Gliogene. Please call us at (650) 736-3846.